Sarepta Therapeutics Inc (SRPT.O)

+ 收藏

资产负债表(Sarepta Therapeutics Inc)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2025年年报2025年三季报2025年中报2025年一季报2024年年报2024年三季报2024年中报2024年一季报
截止日期 2025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表合并报表
报表年结日 12311231123112311231123112311231
原始币种 美元美元美元美元美元美元美元美元
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后上市后
流动资产:
 现金及现金等价物(元) 会员可见会员可见会员可见会员可见1,103,010,000.00197,855,000.00383,622,000.00427,290,000.00
 应收账款及票据(元) 会员可见会员可见会员可见会员可见601,988,000.00434,524,000.00359,997,000.00378,806,000.00
 存货(元) 会员可见会员可见会员可见会员可见749,960,000.00565,924,000.00485,795,000.00373,530,000.00
 短期投资(元) 会员可见会员可见会员可见会员可见251,782,000.001,000,534,000.001,076,852,000.00963,453,000.00
 流动资产其他项目(元) 会员可见会员可见会员可见会员可见366,723,000.00486,532,000.00377,370,000.00321,786,000.00
 流动资产合计(元) 会员可见会员可见会员可见会员可见3,073,463,000.002,685,369,000.002,683,636,000.002,464,865,000.00
非流动资产:
 物业、厂房及设备(元) 会员可见会员可见会员可见会员可见340,336,000.00305,788,000.00276,200,000.00249,302,000.00
 长期投资(元) 会员可见会员可见会员可见会员可见133,163,000.00181,770,000.00--
 非流动资产其他项目(元) 会员可见会员可见会员可见会员可见416,211,000.00427,007,000.00464,421,000.00510,218,000.00
 非流动资产合计(元) 会员可见会员可见会员可见会员可见889,710,000.00914,565,000.00740,621,000.00759,520,000.00
总资产(元) 会员可见会员可见会员可见会员可见3,963,173,000.003,599,934,000.003,424,257,000.003,224,385,000.00
流动负债:
 短期债务及长期负债本期部分(元) -----91,595,000.0091,505,000.00105,586,000.00
 应付账款及票据(元) 会员可见会员可见会员可见会员可见214,442,000.00118,774,000.00107,417,000.0091,536,000.00
 其他应付款及应计费用(元) 会员可见会员可见会员可见会员可见373,513,000.00344,830,000.00350,404,000.00283,317,000.00
 递延收入流动(元) 会员可见会员可见会员可见会员可见130,256,000.00127,001,000.00122,036,000.00112,000,000.00
 流动负债其他项目(元) 会员可见会员可见会员可见会员可见13,473,000.0017,289,000.0017,128,000.0016,270,000.00
 流动负债合计(元) 会员可见会员可见会员可见会员可见731,684,000.00699,489,000.00688,490,000.00608,709,000.00
非流动负债:
 长期债务(元) 会员可见会员可见会员可见会员可见1,137,124,000.001,135,965,000.001,134,810,000.001,133,660,000.00
 融资租赁负债非流动(元) 会员可见会员可见会员可见会员可见192,473,000.00170,009,000.00143,601,000.00140,102,000.00
 递延收入非流动(元) 会员可见--会员可见325,000,000.00325,000,000.00325,000,000.00325,000,000.00
 非流动负债其他项目(元) 会员可见会员可见会员可见会员可见49,150,000.0048,400,000.0055,287,000.0055,722,000.00
 非流动负债合计(元) 会员可见会员可见会员可见会员可见1,703,747,000.001,679,374,000.001,658,698,000.001,654,484,000.00
总负债(元) 会员可见会员可见会员可见会员可见2,435,431,000.002,378,863,000.002,347,188,000.002,263,193,000.00
股东权益:
 普通股(元) 会员可见会员可见会员可见会员可见10,000.0010,000.0010,000.009,000.00
 库存股(元) 会员可见会员可见会员可见-----
 股本溢价(元) 会员可见会员可见会员可见会员可见5,738,924,000.005,588,839,000.005,481,723,000.005,371,968,000.00
 留存收益(元) 会员可见会员可见会员可见会员可见-4,210,974,000.00-4,370,023,000.00-4,403,634,000.00-4,410,094,000.00
 累计其他全面收益(元) 会员可见会员可见会员可见会员可见-218,000.002,245,000.00-1,030,000.00-691,000.00
 归属于母公司股东权益(元) 会员可见会员可见会员可见会员可见1,527,742,000.001,221,071,000.001,077,069,000.00961,192,000.00
 股东权益合计(元) 会员可见会员可见会员可见会员可见1,527,742,000.001,221,071,000.001,077,069,000.00961,192,000.00
负债及股东权益合计(元) 会员可见会员可见会员可见会员可见3,963,173,000.003,599,934,000.003,424,257,000.003,224,385,000.00
公告日期 2026-03-022025-11-062025-08-062025-05-062025-02-282024-11-062024-08-072024-05-01
会计准则 美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则
审计意见
核数师

前瞻产业研究院